Immunocytochemical detection of p21ras, Raf-1, ERK1/MAP kinase and PKC isoforms in a 20-methylcholanthrene-induced transformed murine embryonal fibroblast cells in culture

Neoplasma

Volumn 50, Issue 2, 2003, Pages 131-138

  Banerjee, K ^a   Das, S K ^a   Mukherjee, P ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Chemical carcinogenesis; Components of MAP kinase cascade; PKC isoforms

Indexed keywords

3 METHYLCHOLANTHRENE; ANTIBODY; GENE PRODUCT; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C ZETA; PROTEIN P21; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL GROWTH; CELL LINE; CONTROLLED STUDY; EMBRYO CELL; FIBROBLAST CULTURE; HOST; IMMUNOCYTOCHEMISTRY; MALIGNANT TRANSFORMATION; METABOLISM; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0037991071     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ALDAZ CM, CONTI CJ, CONNELL JO, YUSPA SH, KLEIN-SZANTA AJP, SLAGA TJ. Cytogenetic evidence for gene amplification in mouse skin carcinogenesis. Cancer Research 1986; 46: 3565-3568.
2. AMUNDADOTIR LT, LEDER P. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 1998; 16(6): 737-746.A
3. AZZI A, BOSCOBOINIK D, HENSEY C. The protein kinase C family. Eur J Biochem 1992; 208: 547-557.
4. BALMIAN A. Transforming ras oncogenes and multistage carcinogenesis. Br J Cancer 1985; 51: 1-7.
5. BANASlEWICZ T, MARCINIAK R, MAJEWSKI P, BICZYSKO M, DREWS M. The level of MAP kinase activity in the stomach stump in rats after subtotal gastrectomy. Exp Toxicol Pathol 1998; 50(1): 83-88.
6. BARUACID M. ras genes. Ann Rev Biochem 1987; 56:779-827.
7. BEATTIE GM, KNOWLES AF, JENSEN FC, BAIRD SM, KAPLAN NO. Induction of sarcomas in athymic mice. Proc Natl Acad Sci USA 1982; 79: 3033-3036.
8. BLENIS J. Signal transduction via the MAP Kinases: proceed at your own RSK. Proc Natl Acad Sci USA 1993; 90: 5889-5892.
9. CHOI PM, TEHOU-WONG KM, WEINSTEIN IB. Overexpression of protein kinase C in HT29 colon cells caused growth inhibition and tumor suppression. Mol Cell Biol 1990; 10: 4650-4657.
10. CUADRADO A, BRUDER JT, HEIDARAN MA, APP H, RAPP UR, AARONSON SA. H-ras and raf-1 cooperate in transformation of NIH 3T3 fibroblasts. Oncogene 1993; 8(9): 2443-2448.
11. DAVIS RJ. The mitogen activated protein kinase signal transduction pathway. J Biol Chem 1993; 268: 14553-14556.
12. FEO F, PASCAL RM, SIMILE MM, DE MIGLIO MR, MURONI MR, CALVISI D. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic stategies (Review). Clin Rev Oncogen 2000; 1: 19-62.
13. FRANKS DJ, WHITEFIELD JF, DURKIN JP. Viral P21 Ki-ras protein: a potent intracellular mitogen that stimulates adenylate cyclase activity in early G1-phase of cultured rat cells. J Cell Biochem 1987; 33: 87-94.
14. GALAND P, ALEXANDER K. Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats. Int J Cancer 1988; 41: 155-161.
15. HAGIWAR M, HACHIYA T, WATANABE M, USUDA N, IIDA K, TAMAI K, HIDAKA H. Assessment of protein kinase C isozymes by enzyme immunoassay and overexpression of type II in thyroid adenocarcinoma. Cancer Res 1990; 50: 5515-5519.
16. HARVEY JJ. An unidentified virus which causes the rapid production of tumors in mice. Nature 1964; 204: 1104-1105.
17. HSIAO WL, HOUSEY GM, JOHNSON MD, WEINSTEIN IB. Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. Mol Cell Biol 1989; 9(6): 2641-2647.
18. JUSSILA T, MAKINEN M, STENBACK F. Oncogenes and growth factors a indicators of carcinogen exposure. Exp Toxicol Pathol 1996; 48(2-3): 145-153.
19. KOLCH W, HEIDECKER G, LLOYD P, RAPP UR. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 1991; 31: 426-428.
20. LACAL JC, MOSCAT JS, AARONSON A. Novel source of 1, 2 diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature 1987; 330: 269-272.
21. LA PORTA CAM, TESSITORE L, COMOLLI R. Changes in protein kinase C alpha, delta and in nuclear beta isoform expression in tumor and lung metastatic nodules induced by diethylnitrosamine in the rat. Carcinogenesis 1997; 18: 715-719.
22. MAEMURA M, IINO Y, KOIBUCHI Y, YOKOE T, MORISHITA Y. Mitogen-activated protein kinase cascade in breast cancer (Review). Oncology 1999; 57 Suppl 2: 37-44.
23. MARAIS R, LIGHT Y, PATERSON HFC, MARSHALL J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO-J 1995; 14(3): 3136-3145.
24. MELLONI E, PONTREMOLI S, SPARATORE B, PATRONE M, GROSSI F, MARKS PA, RIFKIND RA. Introduction of the B isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells. Proc Natl Acad Sci 1990; 87: 4417-4420.
25. MISCHAK HJ, PIERCE H, GOODNIGHT J, KOLCH W, MARTINY BARON G, SCHAECHTLE C, KAZANIETZ MG, BLUMBERG PM, PIERCE JH, MUSHINSKI JF. Overexpression of protein kinase C-delta and epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence and tumorigenicity. J Biol Chem 1993; 268: 6090-6096.
26. MORRISON DK, KAPLAN DR, RAPP U, ROBERTS TM. Signal transduction from membrane to cytoplasm: growth factors and membrane bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci 1988; 82(23): 8855-8859.
27. MUKHERJEE P, DAS S. Partial characterization, progressive development and correlations of some neoplastic characters in 20-methylcholanthrene-induced transformed murine embryonal fibroblasts. Cancer Letters 1992; 67: 1-12.
28. MURRAY NR, DAVIDSON LA, CHAPKIN RS, CLAY GW, SEHATTENBERG DG, FIELDS AP. Overexpression of protein kinase C beta II induces colonic hyper proliferation and increased sensitivity to colon carcinogenesis. J Cell Biol 1999; 145(4): 699-711.
29. O'BRIAN CA, WARD NE. Biology of the protein kinase C family. Cancer Metastasis Rev 1989; 8: 199-214.
30. PARK KS, KIM NG, KIM JJ, KIM H, AHN YH, CHOI KY. Differential regulation of MAP Kinase cascade in human colorectal tumorigenesis. Brit J Cancer 1999; 81(7): 1116-1121.
31. PAUL J. Preservation, storage and transportation of living tissue and cells. In: Paul J, editor. Cell and tissue culture. Edinburgh and London: E & S Livingstone, 1970: 308-315.
32. SUKLIMAR S, PULCIANI S, DONIGER J, DI PAOLO JA, EVANS CH, ZBAR B, BARBACID M. A transforming ras gene in tumorigenic guinea pig cell lines initiated by diverse chemical carcinogens. Science 1984; 223: 1197-1199.
33. WATANABE T, ONO Y, TANIYAMA Y, HAZAMA K, IGARASHI K, OGITA K, KIKKAWA U, NISHIZUKA Y. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci USA 1992; 89: 10159-10163.
34. WEINSTEIN IB. Non mutagenic mechanism in carcinogenesis: role of protein kinase C in signal transduction and growth control (Review). Environmental Health Perspectives 1991; 93:175-179.
35. V- src are required, but neither along is sufficient to activate the Raf-1 kinase. Proc Natl Acad Sci 1992; 89: 2922-2926.
36. YIP-SCHNEIDER MT, LIN A, BARNARD D, SWEENEY CJ, MARSHALL MS. Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression. Int J Oncol 1999; 15:271-279.
37. ZELLNER A, FETELL MR, BRUCE JN, DE VIVO DC, O'DRISCOLL KR. Disparity in expression of protein kinase C alpha in human glioma versus glioma-derived primary cell lines, therapeutic implication. Clin Cancer Res 1998; 4(7): 1797-1802.